DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the approval of non-qualified stock option (“Options”) and restricted stock unit (“RSUs”) grants to Inspire’s President and CEO, Adrian Adams, pursuant to NASDAQ Marketplace Rule 5635(c)(4).
